Immunomodulatory aspects of transfusion - A once and future risk?

被引：123

作者：

Klein, HG ^{[1
]}

机构：

[1] NIH, Dept Transfus Med, Warren G Magnuson Clin Ctr, Bethesda, MD 20892 USA

来源：

ANESTHESIOLOGY | 1999年 / 91卷 / 03期

关键词：

blood; immunology; leukoreduction; tolerance;

D O I：

10.1097/00000542-199909000-00040

中图分类号：

R614 [麻醉学];

学科分类号：

100217 ;

摘要：

Immunomodulation seems likely to be added to the list of unintended effects of allogeneic blood transfusion. The magnitude and importance of these effects, the causative agents, and the patients or patient groups that are at particular risk have yet to be defined.

引用

页码：861 / 865

页数：5

共 15 条

[1]

ANDERSON KC, 1990, NEW ENGL J MED, V323, P315

[2] Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis [J].

Artlett, CM ;

Smith, JB ;

Jimenez, SA .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (17) :1186-1191

[3] THE TUMOR GROWTH-PROMOTING EFFECT OF ALLOGENEIC BLOOD-TRANSFUSIONS [J].

BLAJCHMAN, MA ;

BORDIN, JO .

IMMUNOLOGICAL INVESTIGATIONS, 1995, 24 (1-2) :311-317

[4]

Blumberg N, 1996, SEMIN HEMATOL, V33, P329

[5]

BUSCH MP, 1992, BLOOD, V80, P2128

[6] Effect of anaemia and cardiovascular disease on surgical mortality and morbidity [J].

Carson, JL .

LANCET, 1996, 348 (9034) :1055-1060

[7]

Jensen L S, 1998, Curr Opin Hematol, V5, P376, DOI 10.1097/00062752-199811000-00004

[8]

KLEIN HG, 1996, CLIN PRACTICE TRANSF, P59

[9]

LEE TH, IN PRESS BLOOD

[10]

LINDEN JV, 1994, TRANSFUSION ERRORS C, P169

← 1 2 →